Skip to content

Evaluation of Quality of Vision and Spectacle Independence With the AcrySof® Panoptix® Intraocular Lens

Evaluation of Quality of Vision and Spectacle Independence With Bilateral Implantation of the AcrySof® Panoptix® Intraocular Lens

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04124952
Enrollment
30
Registered
2019-10-14
Start date
2019-10-03
Completion date
2021-02-16
Last updated
2023-11-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Keywords

Panoptix, trifocal IOL, multifocal IOL

Brief summary

This is a study to assess the spectacle independence and quality of vision of patients receiving the AcrySof® Panoptix® Intraocular lens (IOL) after uneventful cataract surgery.

Detailed description

This study is a single-arm unmasked clinical evaluation study of spectacle independence after successful bilateral cataract surgery. Subjects will be assessed pre-operatively, operatively and at 1 day, 1 month and 3 months post-operatively. Clinical evaluations will include administration of a spectacle independence questionnaire, as well as measurement of bilateral visual acuity and manifest refraction.

Interventions

DEVICEPanoptix

Alcon Acrysof(R) Panoptix(R) intraocular lens (IOL)

Sponsors

Science in Vision
CollaboratorOTHER
SightTrust Eye Institute
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Subjects are eligible for the study if they meet the following criteria: Note: Ocular criteria must be met in both eyes. * Presenting for uncomplicated bilateral cataract surgery and have an interest in spectacle independence using a multifocal IOL or multifocal toric IOL option * Gender: Males and Females. * Age: 40 or older. * Willing and able to provide written informed consent for participation in the study. * Willing and able to comply with scheduled visits and other study procedures. * Have good ocular health, with no pathology that compromises visual acuity (outside of residual refractive error and cataract) * Have regular corneal astigmatism with a magnitude that can be treated with a non-toric IOL or a toric IOL in the approved ranged for the Panoptix lens. * Have 20/32 (0.2 logMAR) or better potential acuity in both eyes

Exclusion criteria

If any of the following

Design outcomes

Primary

MeasureTime frameDescription
Number of Emmetropic Subjects Who Are Spectacle Independent3 monthsNumber of patients who have a 3-month postoperative manifest spherical equivalent refraction within 0.5 diopters (D) of plano, and ≤ 0.5 D of refractive cylinder (emmetropic subgroup) who never or rarely wear spectacles for distance, intermediate or near vision 3 months postop (based on the Patient-Reported Spectacle Independence Questionnaire (PRSIQ) - a little of the time or none of the time).

Secondary

MeasureTime frameDescription
Binocular Uncorrected Intermediate Visual Acuity3 monthsBinocular logMAR uncorrected intermediate visual acuity
Binocular Uncorrected Near Visual Acuity3 monthsBinocular logMAR uncorrected near visual acuity
Binocular Corrected Distance Visual Acuity3 monthsBinocular logMAR corrected distance visual acuity
Binocular Distance-corrected Intermediate Visual Acuity3 monthsBinocular distance-corrected intermediate visual acuity in logMAR
Binocular Uncorrected Distance Visual Acuity3 monthsBinocular logMAR uncorrected distance visual acuity
Spherical Equivalent Refraction3 monthsSpherical equivalent refraction in diopters
Residual Refractive Cylinder3 monthsResidual refractive cylinder in diopters
Quality of Vision Questionnaire3 monthsQuality of Vision questionnaire results. This is a Rasch-scaled test with scores from 0-100, with lower being better.
Overall Spectacle Independence3 monthspercent of all patients who never or rarely wear spectacles for distance, intermediate or near vision 3 months postop (based on the PRSIQ - a little of the time or none of the time)
Binocular Distance-corrected Near Visual Acuity3 monthsBinocular logMAR distance-corrected near visual acuity

Countries

United States

Participant flow

Participants by arm

ArmCount
Panoptix
Patients bilaterally implanted with the Panoptix intraocular lens. Panoptix: Alcon Acrysof(R) Panoptix(R) intraocular lens (IOL)
29
Total29

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyLost to Follow-up1

Baseline characteristics

CharacteristicPanoptix
Age, Continuous58 years
STANDARD_DEVIATION 7
Race and Ethnicity Not Collected— Participants
Region of Enrollment
United States
29 participants
Sex: Female, Male
Female
17 Participants
Sex: Female, Male
Male
12 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 30
other
Total, other adverse events
1 / 30
serious
Total, serious adverse events
0 / 30

Outcome results

Primary

Number of Emmetropic Subjects Who Are Spectacle Independent

Number of patients who have a 3-month postoperative manifest spherical equivalent refraction within 0.5 diopters (D) of plano, and ≤ 0.5 D of refractive cylinder (emmetropic subgroup) who never or rarely wear spectacles for distance, intermediate or near vision 3 months postop (based on the Patient-Reported Spectacle Independence Questionnaire (PRSIQ) - a little of the time or none of the time).

Time frame: 3 months

Population: This is the number of emmetropic subjects (subgroup)

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
PanoptixNumber of Emmetropic Subjects Who Are Spectacle Independent21 Participants
Secondary

Binocular Corrected Distance Visual Acuity

Binocular logMAR corrected distance visual acuity

Time frame: 3 months

ArmMeasureValue (MEAN)Dispersion
PanoptixBinocular Corrected Distance Visual Acuity0.03 logMAR AcuityStandard Deviation 0.07
Secondary

Binocular Distance-corrected Intermediate Visual Acuity

Binocular distance-corrected intermediate visual acuity in logMAR

Time frame: 3 months

ArmMeasureValue (MEAN)Dispersion
PanoptixBinocular Distance-corrected Intermediate Visual Acuity0.06 logMAR AcuityStandard Deviation 0.1
Secondary

Binocular Distance-corrected Near Visual Acuity

Binocular logMAR distance-corrected near visual acuity

Time frame: 3 months

ArmMeasureValue (MEAN)Dispersion
PanoptixBinocular Distance-corrected Near Visual Acuity0.05 logMAR AcuityStandard Deviation 0.11
Secondary

Binocular Uncorrected Distance Visual Acuity

Binocular logMAR uncorrected distance visual acuity

Time frame: 3 months

ArmMeasureValue (MEAN)Dispersion
PanoptixBinocular Uncorrected Distance Visual Acuity0.07 logMARStandard Deviation 0.09
Secondary

Binocular Uncorrected Intermediate Visual Acuity

Binocular logMAR uncorrected intermediate visual acuity

Time frame: 3 months

ArmMeasureValue (MEAN)Dispersion
PanoptixBinocular Uncorrected Intermediate Visual Acuity0.09 logMARStandard Deviation 0.13
Secondary

Binocular Uncorrected Near Visual Acuity

Binocular logMAR uncorrected near visual acuity

Time frame: 3 months

ArmMeasureValue (MEAN)Dispersion
PanoptixBinocular Uncorrected Near Visual Acuity0.07 logMAR AcuityStandard Deviation 0.11
Secondary

Overall Spectacle Independence

percent of all patients who never or rarely wear spectacles for distance, intermediate or near vision 3 months postop (based on the PRSIQ - a little of the time or none of the time)

Time frame: 3 months

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
PanoptixOverall Spectacle Independence29 Participants
Secondary

Quality of Vision Questionnaire

Quality of Vision questionnaire results. This is a Rasch-scaled test with scores from 0-100, with lower being better.

Time frame: 3 months

ArmMeasureGroupValue (MEAN)Dispersion
PanoptixQuality of Vision QuestionnaireSeverity30.6 Score on a scale (0-100, 0 is best)Standard Deviation 15.1
PanoptixQuality of Vision QuestionnaireFrequency36.9 Score on a scale (0-100, 0 is best)Standard Deviation 16.6
PanoptixQuality of Vision QuestionnaireDegree of bother28.7 Score on a scale (0-100, 0 is best)Standard Deviation 20.7
Secondary

Residual Refractive Cylinder

Residual refractive cylinder in diopters

Time frame: 3 months

ArmMeasureValue (MEAN)Dispersion
PanoptixResidual Refractive Cylinder0.49 dioptersStandard Deviation 0.36
Secondary

Spherical Equivalent Refraction

Spherical equivalent refraction in diopters

Time frame: 3 months

ArmMeasureValue (MEAN)Dispersion
PanoptixSpherical Equivalent Refraction0.06 dioptersStandard Deviation 0.53

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026